PuSH - Publication Server of Helmholtz Zentrum München

Then, C.* ; Herder, C.* ; Heier, M. ; Meisinger, C. ; Koenig, W.* ; Rathmann, W.* ; Sujana, C. ; Roden, M.* ; Bidlingmaier, M.* ; Seissler, J.* ; Thorand, B. ; Peters, A. ; Reincke, M.*

Association of aldosterone with mortality in the general population.

Exp. Clin. Endocrinol. Diabet. 131, 307-313 (2023)
Publ. Version/Full Text DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
INTRODUCTION: Aldosterone excess is linked to cardiovascular events and mortality as well as to low-grade inflammation in the context of metabolic diseases. Whether mildly elevated aldosterone levels in the general population promote cardiovascular risk is still under debate. We analyzed the association of plasma aldosterone concentrations with incident cardiovascular events, cardiovascular and all-cause mortality as well as with biomarkers of subclinical inflammation in the population-based KORA F4 study. RESEARCH DESIGN AND METHODS: Plasma aldosterone concentrations were measured with an inhouse immunoflurometric assay. The analyses included 2935 participants (n = 1076 for selected biomarkers of subclinical inflammation) with a median follow-up of 8.7 (8.2; 9.1) years. The associations were estimated using Cox proportional hazard and linear regression models adjusted for renin, sex, age, BMI, arterial hypertension, diabetes, estimated glomerular filtration rate, low- and high-density lipoprotein cholesterol, physical activity, smoking, use of angiotensin converting enzyme inhibitors, angiotensin receptor blockers, beta blockers, diuretics and calcium channel blockers. RESULTS: Aldosterone was significantly associated with all-cause mortality (hazard ratio per standard deviation increase: 1.20; 95% confidence interval 1.04-1.37), but not with cardiovascular mortality or incident cardiovascular events, nor with biomarkers of subclinical inflammation. CONCLUSIONS: Aldosterone was associated with all-cause mortality, but the previously described associations of excess aldosterone with cardiovascular complications and biomarkers of subclinical inflammation could not be shown in the population-based KORA F4 study.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords General Population ; Myocardial Infarction ; Renin ; Stroke; Myocardial-infarction; Activation
ISSN (print) / ISBN 0947-7349
e-ISSN 1439-3646
Journal Experimental and Clinical Endocrinology & Diabetes
Quellenangaben Volume: 131, Issue: 5, Pages: 307-313 Article Number: , Supplement: ,
Publisher Thieme
Publishing Place Stuttgart
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Epidemiology II (EPI2)
Independent Research Group Clinical Epidemiology (KEPI)
Grants Clinical Cooperation Group Diabetes, Ludwig-Maximilians-University Munchen
Helmholtz Zentrum Munchen
German Diabetes Center
Federal Ministry of Health (Berlin, Germany)
Ministry of Culture and Science of the State of North Rhine Westphalia (Dusseldorf, Germany)
Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF)
State of Bavaria
Virtual Diabetes Institute (Helmholtz Zentrum Munchen)
Deutsche Diabetes Gesellschaft (DDG)
German Research Foundation (DFG)
Else Kroner-Fresenius Stiftung
European Research Council under the European Union
DFG
European Research Council (ERC)
German Federal Ministry of Education and Research (BMBF)